Concepedia

Publication | Closed Access

Epigenetic mechanisms and metabolic reprogramming in fibrogenesis: dual targeting of G9a and DNMT1 for the inhibition of liver fibrosis

85

Citations

37

References

2020

Year

Abstract

Dual G9a/DNMT1 inhibition by compounds like CM272 may be a novel therapeutic strategy for treating liver fibrosis.

References

YearCitations

2007

1.9K

2004

1K

2013

814

2012

777

2016

571

2015

560

2014

527

2012

501

2012

419

2008

405

Page 1